BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3829181)

  • 1. Azinomycins A and B, new antitumor antibiotics. II. Chemical structures.
    Yokoi K; Nagaoka K; Nakashima T
    Chem Pharm Bull (Tokyo); 1986 Nov; 34(11):4554-61. PubMed ID: 3829181
    [No Abstract]   [Full Text] [Related]  

  • 2. Azinomycins A and B, new antitumor antibiotics. I. Producing organism, fermentation, isolation, and characterization.
    Nagaoka K; Matsumoto M; Oono J; Yokoi K; Ishizeki S; Nakashima T
    J Antibiot (Tokyo); 1986 Nov; 39(11):1527-32. PubMed ID: 3793621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azinomycins A and B, new antitumor antibiotics. III. Antitumor activity.
    Ishizeki S; Ohtsuka M; Irinoda K; Kukita K; Nagaoka K; Nakashima T
    J Antibiot (Tokyo); 1987 Jan; 40(1):60-5. PubMed ID: 3104267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical synthesis and cytotoxicity of some azinomycin analogues devoid of the 1-azabicyclo[3.1.0]hexane subunit.
    Hodgkinson TJ; Kelland LR; Shipman M; Suzenet F
    Bioorg Med Chem Lett; 2000 Feb; 10(3):239-41. PubMed ID: 10698444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calphostins, novel and specific inhibitors of protein kinase C. II. Chemical structures.
    Iida T; Kobayashi E; Yoshida M; Sano H
    J Antibiot (Tokyo); 1989 Oct; 42(10):1475-81. PubMed ID: 2478515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of carzinophilin. IV. Structure elucidation by nuclear magnetic resonance spectroscopy. (2).
    Onda M; Konda Y; Hatano A; Hata T; Omura S
    Chem Pharm Bull (Tokyo); 1984 Aug; 32(8):2995-3002. PubMed ID: 6518583
    [No Abstract]   [Full Text] [Related]  

  • 7. Biosynthetic studies on the azinomycins: the pathway to the naphthoate fragment.
    Corre C; Landreau CA; Shipman M; Lowden PA
    Chem Commun (Camb); 2004 Nov; (22):2600-1. PubMed ID: 15543299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biphenomycins A and B, novel peptide antibiotics. II. Structural elucidation of biphenomycins A and B.
    Uchida I; Shigematsu N; Ezaki M; Hashimoto M; Aoki H; Imanaka H
    J Antibiot (Tokyo); 1985 Nov; 38(11):1462-8. PubMed ID: 3841123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel antitumor antibiotic phospholine. 2. Structure determination.
    Ozasa T; Tanaka K; Sasamata M; Kaniwa H; Shimizu M; Matsumoto H; Iwanami M
    J Antibiot (Tokyo); 1989 Sep; 42(9):1339-43. PubMed ID: 2793587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on carzinophilin. I. The properties of carzinophilin A.
    KAMADA H; WAKAKI S; FUJIMOTO Y; TOMIOKA K; UEYAMA S; MARUMO H; UZU K
    J Antibiot (Tokyo); 1955 Dec; 8(6):187-8. PubMed ID: 13319221
    [No Abstract]   [Full Text] [Related]  

  • 11. Resorthiomycin, a novel antitumor antibiotic. II. Physico-chemical properties and structure elucidation.
    Tahara M; Okabe T; Furihata K; Tanaka N; Yamaguchi H; Nishimura T; Suzuki H
    J Antibiot (Tokyo); 1990 Feb; 43(2):135-7. PubMed ID: 2312402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glidobactins D, E, F, G and H; minor components of the antitumor antibiotic glidobactin.
    Oka M; Ohkuma H; Kamei H; Konishi M; Oki T; Kawaguchi H
    J Antibiot (Tokyo); 1988 Dec; 41(12):1906-9. PubMed ID: 3145259
    [No Abstract]   [Full Text] [Related]  

  • 13. SStudies on the metabolites of Zygosporium masonii. II. Structures of zygosporins D, E, F, and G.
    Minato H; Katayama T
    J Chem Soc Perkin 1; 1970; 1():45-7. PubMed ID: 5460654
    [No Abstract]   [Full Text] [Related]  

  • 14. The structures of new antifungal antibiotics, benanomicins A and B.
    Gomi S; Sezaki M; Kondo S; Hara T; Naganawa H; Takeuchi T
    J Antibiot (Tokyo); 1988 Aug; 41(8):1019-28. PubMed ID: 3170340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esperamicins, a novel class of potent antitumor antibiotics. I. Physico-chemical data and partial structure.
    Konishi M; Ohkuma H; Saitoh K; Kawaguchi H; Golik J; Dubay G; Groenewold G; Krishnan B; Doyle TW
    J Antibiot (Tokyo); 1985 Nov; 38(11):1605-9. PubMed ID: 4077737
    [No Abstract]   [Full Text] [Related]  

  • 16. The Fate of Molecular Oxygen in Azinomycin Biosynthesis.
    Kelly GT; Washburn LA; Watanabe CMH
    J Org Chem; 2019 Mar; 84(5):2991-2996. PubMed ID: 30680995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new antitumor antibiotic, bactobolin produced by Pseudomonas.
    Kondo S; Horiuchi Y; Hamada M; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1979 Oct; 32(10):1069-71. PubMed ID: 528370
    [No Abstract]   [Full Text] [Related]  

  • 18. Glidobactins A, B and C, new antitumor antibiotics. II. Structure elucidation.
    Oka M; Yaginuma K; Numata K; Konishi M; Oki T; Kawaguchi H
    J Antibiot (Tokyo); 1988 Oct; 41(10):1338-50. PubMed ID: 3142841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the pyrrolizidine antitumor agent, clazamycin: interconversion of clazamycins A and B.
    Buechter DD; Thurston DE
    J Nat Prod; 1987; 50(3):360-7. PubMed ID: 3668555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the azinomycin naphthoate and central amide in sequence-dependent DNA alkylation and cytotoxicity of epoxide-bearing substructures.
    Coleman RS; Burk CH; Navarro A; Brueggemeier RW; Diaz-Cruz ES
    Org Lett; 2002 Oct; 4(20):3545-8. PubMed ID: 12323065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.